Stay updated on Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial page.

Latest updates to the Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe study page now shows 'No longer looking for participants,' indicating enrollment has closed and no new participants are being recruited. This reflects a recruitment status update to ensure the study record accurately represents current status.SummaryDifference0.2%

- Check17 days agoChange DetectedThe page revision updated from v3.5.4 to v3.5.5, indicating a newer build of the page.SummaryDifference0.0%

- Check39 days agoChange DetectedA new revision tag v3.5.4 was added and the previous revision v3.5.3 was removed.SummaryDifference0.0%

- Check53 days agoChange DetectedThe page revision has been updated from v3.5.2 to v3.5.3, indicating a new version of the page. The underlying study information and content remain the same.SummaryDifference0.0%

- Check67 days agoChange DetectedThe page now displays Revision: v3.5.2, replacing Revision: v3.5.0.SummaryDifference0.0%

- Check96 days agoChange DetectedAdded Revision: v3.5.0; Deleted Revision: v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial page.